ZA200809111B - Substituted carboxamides - Google Patents

Substituted carboxamides

Info

Publication number
ZA200809111B
ZA200809111B ZA200809111A ZA200809111A ZA200809111B ZA 200809111 B ZA200809111 B ZA 200809111B ZA 200809111 A ZA200809111 A ZA 200809111A ZA 200809111 A ZA200809111 A ZA 200809111A ZA 200809111 B ZA200809111 B ZA 200809111B
Authority
ZA
South Africa
Prior art keywords
substituted carboxamides
substituted
carboxamides
formula
pharmaceutically acceptable
Prior art date
Application number
ZA200809111A
Other languages
English (en)
Inventor
Ryan Thomas Backer
Matthew Joseph Fisher
Steven Lee Kuklish
Sean Patrick Hollinshead
Edward C R Smith
Kumiko Takeuchi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200809111B publication Critical patent/ZA200809111B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200809111A 2006-06-08 2008-10-23 Substituted carboxamides ZA200809111B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08

Publications (1)

Publication Number Publication Date
ZA200809111B true ZA200809111B (en) 2009-12-30

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809111A ZA200809111B (en) 2006-06-08 2008-10-23 Substituted carboxamides

Country Status (30)

Country Link
US (1) US7960419B2 (https=)
EP (1) EP2076502B1 (https=)
JP (1) JP5108878B2 (https=)
KR (1) KR101051559B1 (https=)
CN (1) CN101466691B (https=)
AT (1) ATE509921T1 (https=)
AU (1) AU2007347428B2 (https=)
BR (1) BRPI0712862A2 (https=)
CA (1) CA2652074C (https=)
CR (1) CR10410A (https=)
CY (1) CY1111588T1 (https=)
DK (1) DK2076502T3 (https=)
EA (1) EA014233B1 (https=)
EC (1) ECSP088939A (https=)
ES (1) ES2362949T3 (https=)
HR (1) HRP20110436T1 (https=)
IL (1) IL195632A (https=)
MA (1) MA30620B1 (https=)
MX (1) MX2008015485A (https=)
MY (1) MY148084A (https=)
NO (1) NO341474B1 (https=)
NZ (1) NZ573352A (https=)
PL (1) PL2076502T3 (https=)
PT (1) PT2076502E (https=)
RS (1) RS51818B (https=)
SI (1) SI2076502T1 (https=)
TN (1) TNSN08506A1 (https=)
UA (1) UA95480C2 (https=)
WO (1) WO2008103185A2 (https=)
ZA (1) ZA200809111B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
EP2276759B1 (en) 2008-04-04 2011-10-19 Eli Lilly & Company 3-indazolyl-4-pyridylisothiazoles
WO2010146338A1 (en) * 2009-06-15 2010-12-23 The University Of Edinburgh Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
US8642621B2 (en) 2009-09-16 2014-02-04 The University Of Edinburgh (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
AU2011247116B2 (en) 2010-04-29 2015-12-03 The University Of Edinburgh 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1H - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -HSD1
DK2921489T3 (en) 2012-11-13 2017-10-16 Nissan Chemical Ind Ltd 2-pyridone-RELATED
CA3037642A1 (en) 2016-09-23 2018-03-29 Bayer Aktiengesellschaft N 3 -cyclically substituted thienouraciles and use thereof
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
AU2002342607B2 (en) * 2001-08-06 2006-10-19 Pharmacia Italia S.P.A. Aminoisoxazole derivatives active as kinase inhibitors
EP1667983A4 (en) * 2003-09-23 2010-07-21 Merck Sharp & Dohme PYRAZOL MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
CN1984899B (zh) * 2004-05-12 2011-07-27 先灵公司 Cxcr1和cxcr2趋化因子拮抗剂
MX2007003377A (es) * 2004-09-23 2007-05-10 Pfizer Prod Inc Agonistas del receptor de trombopoyetina.

Also Published As

Publication number Publication date
NO341474B1 (no) 2017-11-27
AU2007347428B2 (en) 2012-02-09
NO20085028L (no) 2008-12-02
ATE509921T1 (de) 2011-06-15
PL2076502T3 (pl) 2011-09-30
NZ573352A (en) 2011-10-28
EP2076502A2 (en) 2009-07-08
IL195632A0 (en) 2009-09-01
EA014233B1 (ru) 2010-10-29
AU2007347428A1 (en) 2008-08-28
MX2008015485A (es) 2009-03-06
US20090182025A1 (en) 2009-07-16
CA2652074A1 (en) 2008-08-28
JP5108878B2 (ja) 2012-12-26
CR10410A (es) 2008-11-28
ECSP088939A (es) 2009-01-30
EP2076502B1 (en) 2011-05-18
CN101466691B (zh) 2011-07-27
RS51818B (sr) 2011-12-31
DK2076502T3 (da) 2011-07-25
KR20090008460A (ko) 2009-01-21
UA95480C2 (uk) 2011-08-10
KR101051559B1 (ko) 2011-07-22
EA200870516A1 (ru) 2009-06-30
WO2008103185A3 (en) 2008-10-30
SI2076502T1 (sl) 2011-09-30
CA2652074C (en) 2013-08-06
WO2008103185A2 (en) 2008-08-28
HRP20110436T1 (hr) 2011-08-31
US7960419B2 (en) 2011-06-14
PT2076502E (pt) 2011-06-07
BRPI0712862A2 (pt) 2012-12-18
IL195632A (en) 2013-11-28
TNSN08506A1 (en) 2010-04-14
CY1111588T1 (el) 2015-10-07
ES2362949T3 (es) 2011-07-15
MA30620B1 (fr) 2009-08-03
MY148084A (en) 2013-02-28
CN101466691A (zh) 2009-06-24
HK1131984A1 (en) 2010-02-12
JP2009539874A (ja) 2009-11-19

Similar Documents

Publication Publication Date Title
IL195632A0 (en) Substituted carboxamides
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
TW200806299A (en) Treatment of pain
TW200806300A (en) New therapeutic combinations for the treatment of depression
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
SI2205244T1 (sl) Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
IL193252A0 (en) N-hydroxyacrylamide compounds
TW200738653A (en) Anthranilamide/2-amino-heteroarene carboxamide derivatives
MX2009005798A (es) Recuperacion de apoplejia.
TW200639159A (en) Treatment of pain
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TW200806321A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2010008586A (es) Amidas de acido 3-(4-fluorofenil)-3-hidroxi-2-amino-propionico y compuestos relacionados que tienen actividad analgesica.
IL197769A (en) The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
WO2007144889A3 (en) Treatment of neurofibromatosis
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
MX2009010164A (es) Metodo para tratar dolor mediado por el receptor cb2.
MX2009010162A (es) Metodo para tratar dolor mediado por el receptor cb2.
EA200701086A1 (ru) Производные изоксазола, их фармацевтические композиции и способ лечения невропатической боли
DOP2008000064A (es) Carboxamidas sustituidas.
UA103767C2 (ru) Карбоксамидные соединения для лечения метаболических расстройств